Jessica Boyce, MD
Internal Medicine · New Orleans, LANPI 1821626342
Payments from drug & device makers
Across 12 payments — averaging $38.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$100
- Revance Therapeutics, Inc.$93
- Novartis$59
- Jazz Pharmaceuticals Inc.$38
- Sanofi$30
- Daiichi Sankyo Inc.$28
- plus $108 from 5 others
What the payments were for
- Food & beverage$35678%
- Education$10022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Revance Therapeutics, Inc. | 1 | $93 |
| Novartis | 2 | $59 |
| Jazz Pharmaceuticals Inc. | 1 | $38 |
| Sanofi | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Merck | 1 | $26 |
| Bayer | 1 | $24 |
| EMD Serono, Inc. | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
How this compares
$456 in reported general payments places this provider in the 50th percentile of 1,528 internal medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 31 | $23,932 |
| EliquisApixaban | 17 | $9,913 |
| CreonLipase/Protease/Amylase | 11 | $5,481 |
| Amiodarone Hcl | 11 | $358 |
| Pantoprazole Sodium | 14 | $349 |
| Metoprolol Succinate | 28 | $297 |
| Losartan Potassium | 20 | $218 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $181 |
| Ondansetron OdtOndansetron | 15 | $172 |
| ClopidogrelClopidogrel Bisulfate | 14 | $153 |
| Carvedilol | 19 | $118 |
| Nifedipine ErNifedipine | 11 | $111 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $104 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $102 |
| Atorvastatin Calcium | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New Orleans
- William SmithNew Orleans$50.5M
- Brian LewisNew Orleans$2M
- Steven DeitelzweigNew Orleans$939K
- Lydia BazzanoNew Orleans$892K
- Eboni Price-HaywoodNew Orleans$659K
- Susan Lewis AbdalianNew Orleans$301K
- Eduardo RodriguezNew Orleans$167K
- Shigeki SaitoNew Orleans$120K
- Jonathan GugelNew Orleans$95K
- Keith WinfreyNew Orleans$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.